Literature DB >> 14653691

Bivalent transition-state analogue inhibitors of human glyoxalase I.

Zhe-Bin Zheng1, Donald J Creighton.   

Abstract

A new class of competitive inhibitors of homodimeric human glyoxalase I has been created by cross-linking two molecules of the transition-state analogue S-(N-4-chlorophenyl-N-hydroxycarbamoyl)glutathione (CHG) through their gamma-glutamyl-NH(2) groups with poly-beta-alanyl tethers of differing length: [CHG(beta-ala)n](2) suberate diamide (n = 1-7). The strongest inhibitors of this antitumor target enzyme likely bind simultaneously to the active site on each subunit to give K(i) values as small as 0.96 nM (n = 6). [structure: see text]

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14653691     DOI: 10.1021/ol035917s

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  2 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I.

Authors:  Makoto Kawatani; Hideo Okumura; Kaori Honda; Naoki Kanoh; Makoto Muroi; Naoshi Dohmae; Masamichi Takami; Mitsuhiro Kitagawa; Yushi Futamura; Masaya Imoto; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.